Minimizing factor requirements for surgery without increased risk

Haemophilia, Supplement

Volumn 10, Issue 4, 2004, Pages 35-40

  Schulman, Sam ^a   Loogna, J ^a   Wallensten, R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bleeding; Continuous infusion; Haemophilia; Orthopaedic surgery

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; BLOOD CLOTTING FACTOR CONCENTRATE; FIBRIN GLUE; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; TRANEXAMIC ACID;

ANAPHYLAXIS; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG HALF LIFE; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; ORTHOPEDIC SURGERY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; STEADY STATE; SURGICAL RISK; SURGICAL TECHNIQUE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FACTOR IX; FACTOR VIII; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 11044236959     PISSN: 13550691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Horoszowski H, Heim M, Schulman S, Varon D, Martinowitz U. Multiple joint procedures in a single operative session on hemophilic patients. Clin Orthop 1996; 328: 60-4.
2. Ong YL, Hull DR, Mayne EE. Menorrhagia in von Willebrand disease successfully treated with single daily dose tranexamic acid. Haemophilia 1998; 4: 63-5.
3. Ramström G, Sindet-Pedersen S, Hall G, Blombäck M, Ålander U. Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. J Oral Maxillofac Surg 1993; 51: 1211-6.
4. Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003; 31: 529-37.
5. Schulman S, Wallensten R, White B, Smith OP. Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery. Haemophilia 1999; 5: 96-100.
6. Schulman S. Continuous infusion. Haemophilia 2003; 9 368-75.
7. Schulman S, d'Oiron R, Martinowitz U et al. Experiences with continuous infusion of recombinant activated factor VII. Blood Coagul Fibrinolysis 1998; 9 (Suppl. 1): S97-S101.
8. Rakocz M, Mazar A, Varon D, Spierer S, Blinder D, Martinowitz U. Dental extractions in patients with bleeding disorders. The use of fibrin glue. Oral Surg Oral Med Oral Pathol 1993; 75: 280-2.
9. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Jt Surg Am 1999; 81: 1580-8.
10. Isarangkura P, Chiewsilp P, Chuansumrit A et al. Low cost locally prepared fibrin glue for clinical applications: reported of 145 cases. Committee of Bangkok International Hemophilia Training Center. J Med Assoc Thai 1999; 82: S49-56.
11. Blinder D, Manor Y, Martinowitz U, Taicher S. Dental extractions in patients maintained on continued oral anticoagulant: comparison of local hemostatic modalities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 137-40.
12. Hermens WTH. Dose calculation of human factor VIII and factor IX concentrates for infusion therapy. In: Brinkhouse KM, Hemker HC, eds. Handbook of Hemophilia: Part II. New York: America Elsevier Publishing Co, 1975: 569-89.
13. Hathaway WE, Christian MJ, Clarke SL, Hasiba U. Comparison of continuous and intermittent factor VIII concentrate therapy in hemophilia A. Am J Hematol 1984; 17: 85-8.
14. Martinowitz U, Schulman S, Gitel S, Horoszowski H, Heim M, Varon D. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. Br J Haematol 1992; 82: 729-34.
15. Batorova A, Martinowitz U. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery. Br J Haematol 2000; 110: 715-20.